Biotech
Spanish Biotech Integra Therapeutics Secures Licensing Deal with Caszyme to Boost Gene Editing Capabilities
Spanish biotech firm Integra Therapeutics has announced a strategic agreement to enhance its gene editing capabilities by licensing Cas12I nucleases...
Read more
Sana Biotechnology to Pivot Cancer Therapy Focus Toward Autoimmune Diseases, Warns of Potential Layoffs
Sana Biotechnology, a leader in cell therapy innovation, has announced a major shift in its strategic priorities, reallocating resources from...
Read more
Cellectis Shifts Focus, Drops Leukemia CAR-T Candidate to Prioritize Two Key Therapies
Biotech company Cellectis has announced a strategic shift in its CAR-T therapy pipeline, choosing to deprioritize UCART123, a leukemia-targeted candidate,...
Read more
Viking Therapeutics’ Oral Obesity Drug Shows Promising 6.8% Weight Loss, Boosting Stock as Phase 1 Data Rolls Out
In the competitive arena of oral obesity treatments, Viking Therapeutics has made a strong showing with its obesity medication VK2735,...
Read more
Boehringer Ingelheim Ends Development of Obesity Drug in Gubra Partnership
In a recent announcement, Boehringer Ingelheim has decided to end the development of one of its obesity drug candidates from...
Read more
Roche Advances Alzheimer’s Blood Tests with Promising New Data
Roche has unveiled fresh data supporting two of its innovative blood tests, designed to assist in diagnosing Alzheimer’s disease with...
Read more
Oura Buys Sparta Science, Its Third Acquisition in 2 Years
Smart ring maker Oura on Thursday announced that it has acquired Sparta Science, a Bay Area-based health tracking startup. TechCrunch spoke to...
Read more
Compass Pathways Delays Key Phase 3 Data for Psilocybin Therapy, Cuts 30% of Workforce
Compass Pathways, a leading player in psychedelic-based mental health treatments, has announced a significant delay in the release of data...
Read more
Ventus Therapeutics Advances Daily Oral Lupus Treatment with Promising Phase 1 Results
In a lupus treatment market set for rapid transformation, Ventus Therapeutics is preparing to break new ground with its investigational...
Read more
Spero Therapeutics’ Antibiotic Setback Leads to Major Workforce Cut
Spero Therapeutics is facing a significant setback after its oral antibiotic candidate, SPR720, failed to show effectiveness in a recent...
Read more
